Oncocyte Corporation Announces Pricing of Registered Direct Offering of 11,765 Shares of Series A Convertible Preferred Stock

April 13, 2022

Biotechnology

Obsidian Therapeutics and Galera Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement

April 14, 2026
PharmaTher Announces Filing of U.S. Patent Application for its Peptide Microneedle Patch Technology

April 13, 2026
The Radoff-JEC Group Submits Non-Binding Proposal to Acquire Seer, Inc.

April 13, 2026
BiomX Accelerates Defense Technology Buildout with DFSL Acquisition

April 13, 2026